Search Results 31-40 of 11361 for ���������������������������:za33���24������ ������������������������ ������

  1. Oncology (Medical) - Clinical trials - Mayo Clinic

    Go to page 2424 · Go to page 2525 · Go to page 2626 · NextNext Page · Request an appointment · Expertise & rankingsResearch. Dec. 24, 2024. Share on: Facebook ...

  2. Long-Term Safety of Previous Treatment With Applicable Cell and Gene Therapy Products in Other AstraZeneca Studies - Mayo Clinic

    Scottsdale/Phoenix, Arizona: 24-005505; Jacksonville, Florida: 24-005505. NCT ID: NCT06194461. Sponsor Protocol Number: D9341C00001. About this study. The ...

  3. Breast cancer - Doctors and departments - Mayo Clinic

    Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.

  4. Breast cancer - Doctors and departments - Mayo Clinic

    Has anyone taken Lynparza? 24 Replies Sat, Jun 07, 2025. See more discussions. Related. Breast cancer chemoprevention · Breast Cancer Education Tool · Breast ...

  5. OHF Patient Registry - Mayo Clinic

    Rochester, Minnesota: 24-007676. About this study. The purpose of this study is that the Oxalosis and Hyperoxaluria Foundation (OHF) Registry in collaboration ...

  6. Prostate cancer - Symptoms and causes - Mayo Clinic

    12th ed. Wolters Kluwer; 2023. Accessed Sept. 24, 2024. Prostate cancer treatment (PDQ) — Patient version. National Cancer Institute. https://www.cancer.gov/ ...

  7. Clinical Trials

    Rochester, Minnesota: 24-000321; Scottsdale/Phoenix, Arizona: 24-000321. NCT ID: NCT06962995. Sponsor Protocol Number: 24-000321. About this study. Novel ...

  8. Implantable cardioverter-defibrillators (ICDs) - Doctors & Departments - Mayo Clinic

    Accessed April 24, 2023. Living with your implantable cardioverter defibrillator (ICD). https://www.heart.org/en/health-topics/arrhythmia/prevention ...

  9. A Study of an FGFR2/3 Inhibitor (CGT4859) in Patients With Cholangiocarcinoma and Other Advanced Solid Tumors - Mayo Clinic

    Sponsor Protocol Number: CGT4859-24-101. About this study. This is an open-label, phase 1/2 study evaluating the safety, tolerability, pharmacokinetic (what ...

  10. Publications - Zaiyang Long, Ph.D. - Mayo Clinic

    2023 May; 24 (5):e13962 Epub 2023 Mar 21. View PubMed; Long Z, Walz-Flannigan AI, Littrell LA, Schueler BA. Technical note: Four-year experience with ...